Today: 30 June 2026
Rio Tinto share price today: RIO.L stock edges up after earnings miss, cost outlook
20 February 2026
1 min read

Rio Tinto share price today: RIO.L stock edges up after earnings miss, cost outlook

London, February 20, 2026, 08:48 GMT — Regular session

Rio Tinto’s London shares (RIO.L) added 36 pence to hit 7,154 pence by 08:48 GMT, up roughly 0.5% from Tuesday’s 7,118 pence close. The stock moved between 7,086 and 7,162 pence, hovering close to its 52-week highs.

Rio’s annual results landed Thursday. The miner’s underlying earnings — which exclude certain one-off items — came in flat, coming up short of forecasts after softer iron ore prices pressured its largest segment. Underlying earnings clocked in at $10.87 billion for 2025, missing the $11.03 billion consensus from Visible Alpha. Pilbara unit cost guidance landed at $23.50 to $25 a tonne for 2026. “A good result, perhaps not as impressive as BHP,” offered Andy Forster of Argo Investments, as investors also digested the company’s move to walk away from merger talks with Glencore. Reuters

Rio is putting more weight behind copper and other so-called “future-facing” metals, as its Pilbara iron ore operations take a back seat after years in the spotlight. “Safety remains our highest priority,” Chief Executive Simon Trott said. The miner reported an 8% bump in copper-equivalent production and said it’s sticking with a 60% dividend payout ratio. Rio also flagged a target of $5 billion to $10 billion in cash proceeds from its existing asset base, highlighting plans to market-test borates and titanium dioxide feedstock, and to monetize infrastructure. riotinto.com

Lithium’s in the mix as well. On Wednesday, Rio announced it now holds a 53.9% stake in Canada’s Nemaska Lithium, assuming management control. Quebec’s government, meanwhile, retains its 46.1% share.

Miners have been navigating choppy conditions lately. Copper’s been knocked around by a stronger U.S. dollar and a slowdown in Chinese buying tied to the Lunar New Year. Risk sentiment has wobbled too, as U.S.-Iran friction sent oil prices climbing.

Right now, traders are weighing whether Friday’s early bounce signals more than just a relief rally following results. What they’re watching for next: any word on timing and pricing around asset sales, plus clues on whether cost pressure in Western Australia lets up as the year rolls on.

Still, the risk is clear. Should iron ore remain under pressure while expenses tick up, Rio’s cash flow could get squeezed, particularly with ongoing outlays for new copper and lithium projects.

One notable date coming up for investors: Rio’s final dividend, set at 254 U.S. cents, goes ex-dividend March 5. The payment lands April 16.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • SpaceX Sells $25 Billion in Debt After $86 Billion IPO to Cover xAI Deal, Fund Projects
    June 30, 2026, 11:36 AM EDT. SpaceX raised $86 billion in its IPO, then moved quickly to sell $25 billion in debt to pay back a bridge loan used for its xAI purchase. The debt sale came in above early targets, with strong demand from investors. The company's capex keeps climbing, especially for AI work, hitting $10.1 billion in the first quarter, up more than twofold from last year. SpaceX continues to burn cash as it pushes major projects like space-based data centers and Mars rockets, so it's leaning on both the equity and debt market to fund expansion. The stock's high price and the company's frequent trips to the market mean investors face ongoing risks.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop